Nexus Precision Health (“Nexus”), a precision medicine technology company, announces it has acquired Leal Health, the AI-powered patient decision-support platform. The acquisition creates an integrated platform designed to match patients with cancer, rare genetic diseases, and mental health conditions to the right therapy, clinical trial, or expanded access pathway—at scale. Leal Health brings a patented GEN- AI engine that generates personalized treatment plans, along with a live ecosystem of 40,000+ clinicians, 90+ biopharma partners, and engagements with two of the five largest U.S. health insurers.
Read the full article: Nexus Precision Health Acquires Leal Health to Accelerate Precision Medicine at Scale //
Source: https://www.prnewswire.com/news-releases/nexus-precision-health-acquires-leal-health-to-accelerate-precision-medicine-at-scale-302697365.html